Adenosinergic system as an endogenous anticonvulsant mechanism

Indian Journal of Physiology and Pharmacology

Volumn 41, Issue 4, 1997, Pages 329-343

  Gupta, Y K ^a   Malhotra, Jatinder ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Adenosine; Adenosine receptors; Adenosinergic system; Antiepileptic drugs; Endogenous anticonvulsant substance(s); Seizures

Indexed keywords

ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE RECEPTOR; ANTICONVULSIVE AGENT; RECEPTOR SUBTYPE;

ANTICONVULSANT ACTIVITY; EPILEPSY; HUMAN; REVIEW; SEIZURE;

ADENOSINE; ANIMALS; ANTICONVULSANTS; DRUG THERAPY, COMBINATION; HUMANS; RECEPTORS, PURINERGIC P1; SEIZURES;

EID: 0030696354     PISSN: 00195499     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (111)

1. Stables JP, Bialer M, Johannessen SI, Kupferberg HJ, Levy RH, Loiseau R, Perucca E. Progress report on new antiepileptic drugs a summary of the second Eliat conference. Epilepsy Res 1995; 22 : 235-246.
2. Beghi E, Perruca E. The management of epilepsy in the 1990s. Drugs 1995; 49 : 680-694.
3. Dragunow M. Endogenous anticonvulsant substances. Neurosci Biobehav Rev 1986a; 10: 229-244.
4. Dragunow M. Adenosine:the brain's natural anticonvulsant? Trends Pharmacol Sci 1986b; 7 : 128-130.
5. Plum F, Posner JB, Troy B. Cerebral metabolic and circulatory responses to induced convulsions in animals. Arch Neural 1968; 18: 1-13.
6. Kreisman NR, Rosenthal M, LaManna JC, Siek TJ. Cerebral oxygenation during recurrent seizures. Adv Neurol 1983; 34:231-239.
7. Caspers H, Speckmann EJ. Cerebral pO2, pCO2 and pH changes during convulsive activity and their significance for spontaneous arrest of seizures. Epilepsia 1972; 13 :699-725.
8. Dow RS. Extrinsic regulatory mechanisms of seizure activity. Epilepsia 1965; 6: 122-140.
9. Kreindler A, Active arrest mechanisms of epileptic seizures. Epilepsia 1962; 3 : 329-337.
10. Somjen GG. Extracellular potassium in the mammalian centra nervous system. Annu Rev Physiol 1979; 41 :159-177.
11. Prince DA, Pedley TA, Ransom BR. Fluctuation in ion concentrations during excitation and seizures. In: Dynamic Properties of Glia Cells. Schoffeniels E, Franck G, Tower DB and Hertz L (Eds.), London, Pergamon Press, (1978): 281-303.
12. Kaczmarek LR, Kauer JA. Calcium entry causes a prolonged refractory period in peptidergic neurons of Aplysia. J Neurosci 1983; 3 : 2230-2239.
13. Dakin KA, Weaver DF. Rational design of anticonvulsants : A quantum pharmacologic study of the ion channel - modulating FMRF amide tetrapeptide as an endogenous anticonvulsant. Epilepsia 1995; 36 : 494-507.
14. Delgado-Escueta AV. Summation of the workshops and discussion : the new wave of research in the epilepsies. Ann Neurol 1984; 16 (suppl) : S145-S158.
15. Delgado-Escueta AV, Ward AA, Jr. Woodbury M, Porter RJ. New wave of research in the epilepsies, In : Delgado - Escueta, A.V., and Ward A. A., Jr. Woodbury, D.M. and Porter, R.J., eds. Basic mechanisms of the epilepsies : molecular and cellular approaches, 1986, New York : Raven Press, pp 3-55.
16. Tortella FC. Endogenous opioid peptides and epilepsy: quieting the seizing brain. Trends Pharmacol Sci 1988; 9: 366-372.
17. Bengzon J, Kokaia Z, Lindvall O. Specific functions of grafted locus coeruleus neurons in the kindling model of epilepsy. Exp Neural 1993; 122 : 143-154.
18. Browning RA, Wang C, Faingold CL. Effect of norepinephrine depletion on audiogenic-like seizures elicited by microinfusion of an excitant amino acid into the inferior colliculus of normal rats. Exp Neurol 1991;, 112: 200-205.
19. Laird HE, Dailey JW, Jobe PC. Neurotransmitter abnormalities in genetically epileptic rodents. Fed Proc 1984; 43 : 2505-2509.
20. Mason ST, Corcoran ME. Catecholamines and convulsions. Brain Res 1979; 170 : 497-507.
21. Mishra PK, Kahle EH, Bettendorf AF, Dailey JW, Jobe PC. Anticonvulsant effects of intracerebroventricularly administered norepinephrine are potentiated in the presence of monoamine oxidase inhibition in severe seizure genetically epilepsy-prone rats (GEPR-9s). Life Sci 1993; 52 : 1435-1441.
22. Sullivan HC, Osorio I. Aggravation of penicillin - induced epilepsy in rats with locus coeruleus lesions. Epilepsia 1991; 32 : 591-596.
23. Killam EK, Killam KF. Evidence for neurotransmitter abnormalities related to seizure activity in the epileptic baboon. Fed Proc 1984; 43: 2510-2515.
24. Welsh KA, Kingslow L, Gold PE. Effects of a single epinephrine injection on amygdala seizures and kindling. Soc Neurosci Abstr 1982; 8 : 87.
25. Gee KW, Killam EK, Hollinger MA. Effects of haloperidol induced dopamine receptor supersensitivity on kindled seizure development. J Pharmacol Exp Ther 1983; 225 : 70-76.
26. Snead OC. On the sacred disease : The neurochemistry of epilepsy. Int Rev Neurobiol 1983; 24 : 93-180.
27. Callaghan DA, Schwark WS. Involvement of catecholamines in kindled amygdaloid convulsion in the rat. Neuropharmacology 1979; 18 : 541-545.
28. Alam AM, Starr MS. Dopaminergic modulation of piloocarpine-induced motor seizures in the rat : the role of hippocampal D2 receptors. Neuroscience 1993; 53 : 425-431.
29. Bo P, Soragna D, Marchioni E, Candeloro E, Albergati A, Savoldi F. Role of dopamine, D-I and D-2 antagonist in a model of focal epilepsy induced by electrical stimulation of hippocampus and amygdala in the rabbit. Prog Neuropsychopharmacol Biol Psychiatry 1995; 19 : 917-930.
30. Pasini A, Tortorella A, Gale K. Anticonvulsant effect of intranigral fluoxetine. Brain Res 1992; 593 : 287-290.
31. Racine RJ, Coscina DV. Effects of midbrain raphe lesions or systemic p-chlorophenylalanine on the development of kindled seizures in rats. Brain Res Bull 1979; 4 : 1-7.
32. Champney TH, Champney JA. Novel anticonvulsant action of chronic melatonin in gerbils. Neuroreport 1992; 3 : 1152-1154.
33. Albertson TE, Paterson SL, Stark LG, Lakin ML, Winters WD. The anticonvulsant properties of melatonin on kindled seizure in rats. Neuropharmacology 1981; 20 : 61-66.
34. Onodera K, Tuomisto L, Tacke U, Airaksinen M. Strain differences in regional brain histamine levels between genetically epilepsy - prone and resistant rats. Meth Find Exp Clin Pharmacol 1992; 14 : 13-16.
35. 1 antagonists on electrically - induced seizure in developing mice. Psychopharmacology 1993; 112 : 199-203.
36. Greunthal M, Ault B, Armstrong DR, Nadler JV. Baclofen blocks kainic acid-induced epileptiform activity. Soc Neurosci Abstr 1984; 10 : 184.
37. Booker JG, Dailey JW, Jobe PC, Lane JD. Cerebral cortical GABA and benzodiazepine binding sites in genetically seizure prone rats. Life Sci 1986; 39 : 799-806.
38. Hattori H, Ito M, Mikawa H. Gamma - aminobutyric acid benzodiazepine binding sites and GABA concentrations in epileptic E1 mouse brain. Ear J Pharmacol 1985; 119 : 217-233.
39. Marangos PJ, Loftus T, Wiesner J, Lowe T, Rossi E, Browne CE, Gruber HE. Adenosinergic modulation of homocysteine-induced seizures in mice. Epilepsia 1990; 31 : 239-246.
40. Petersen EN. Selective protection by adenosine receptor agonists against DMCM-induced seizures. Eur J Pharmacol 1991; 195 : 261-265.
41. Von Lubitz DKJE, Paul IA, Carter M, Jacobson KA. Effects of N-cyclopentyl adenosine and 8-cyclopentyl-1, 3-dipropylxanthine on N-methyl-D-aspartate induced seizures in mice. Eur J Pharmacol 1993; 249 : 265-270.
42. Dragunow M, Goddard GV. Adenosine modulation of amygdala kindling. Exp Neurol 1984; 84 : 654-665.
43. Whitcomb K, Lupica CR, Rosen JB, Berman RF. Adenosine involvement in postictal events in amygdala-kindled rats. Epilepsy Res 1990; 6: 171-179.
44. Lewin E, Bleck V. Electroshock seizures in mice: effect on brain adenosine and its metabolites. Epilepsia 1981; 19: 577-581.
45. Lewin E, Bleck V. Effect of inosine on seizures induced with metrazol, bicuculline, or picrotoxin. Epilepsia 1985; 26 : 258-261.
46. Forstermann U, Heldt R, Knappen F, Hertting G. Potential anticonvulsive properties of endogenous prostaglandins formed in mouse brain. Brain Res 1982; 240 : 303-310.
47. Wali RS, Nair PA. Aspirin and anticonvulsant interaction. Indian J Physiol Pharmacol 1995; 39 : 77-79.
48. Wallenstein MC. Differential effect of prostagiandin synthase inhibitor pretreatment on metrazol-induced seizures in rat. Arch lnt Pharmacodyn Ther 1985; 275 : 93-104.
49. Forstermann U, Seregi A, Hertting G. Anticonvulsive effects of endogenous prostaglandin formed in brain of spontaneously convulsive gerbils. Prostaglandins 1984; 27 : 913-923.
50. Gamaniel K, Wuorela H, Vapaatalo H. Effects of iloprost, prostaglandin E1 (PGE1) on chemically and electrically induced seizures in mice. Prostaglandins Leukot Essent Fatty Acids 1989; 35 : 63-68.
51. Croucher MJ, Marriott DR, Bradford HF, Wilkin GP. Lack of effect of focally administered Prostaglandins on electrically kindled seizure activity. Prostaglandins 1991; 42 ; 29-38.
52. Holmes GL, Weber BS. Effects of ACTH on seizure susceptibility in the developing brain. Ann Neurol 1986; 20 : 82-88.
53. Kubek MJ, Meyerhoff JL, Hill TG, Norton JA, Sattin A. Effect of subconvulsive and repeated ECS on TRH in rat brain. Life Sci 1985; 36: 315-320.
54. Meyerhoff JL, Bates VE, Kubek MJ. Increases in brain TRH following kindled seizures. Soc Neurosci Abstr 1982; 8: 457.
55. Sato M, Morimoto K, Wada JA. Antiepileptic effects of TRH and its new derivative, DN-1417, examined in feline amygdaloid kindling preparation. Epilepsia 1984; 25: 537-544.
56. Renming X, Ishihara K, Sasa M, Ujihara H, Momiyama T, Fujita Y, Todo N, Serikawa T, Yamada J, Takaori S. Antiepileptic effects of CNK-602A, a novel thyrotropin - releasing hormone analog, on absence like and tonic seizures of spontaneously epileptic rats. Eur J Pharmacol 1992; 223: 185-192.
57. Perlin JB, Lothman EW, Geary WA II. Somatostatin augments the spread of limbic seizures from the hippocampus. Ann Neurol 1987; 21. 475-480.
58. Wolf-Dieter R, Heuschneider G, Sperk G, Riederer P. Biochemical events in spontaneous seizures in the Mongolian gerbil. Metab Brain Dis 1989; 4: 3-7.
59. Perez OE, Lopez RMP, Gonzalez GL, Arilla E. Cystamine normalizes cerebral somatostatin level and binding in pentylenetetrazone - kindled rats. Life Sci 1989; 45: 2451-2458.
60. Mazarati AM, Telegdy B. Effects of somatostatin and antisomatostatin serum on picrotoxin-kindled seizures. Neuropharmacology 1992; 31 : 793-797.
61. Higuchi T, Kokubu G, Sikand GS. A study of somatostatin receptors in the amygdaloid-kindled rat brain. J Neurochem 1984; 43: 1272-1276.
62. Horn AC, Leppik IE, Rask CA. Effects of estradiol and progesterone on seizure sensitivity in oophorectomized DBA/2J mice and C57/EL hybrid mice. Neurology 1993; 43: 198-204.
63. Schwartz GS, Korotzer A, Pfaff DW. Steroid hormone effects on picrotoxin-induced seizures in female and male rats. Brain Res 1989; 476: 240-247.
64. Belelli D, Bolger MB, Gee KW. Anticonvulsant profile of the progesterone metabolite 5 alpha-pregnan-3-alpha-ol 20-one. Eur J Pharmacol 1989; 166: 325-329.
65. Holmes GL, Weber BS. The effects of progesterone on kindling: a developmental study. Dev Brain Res 1984; 16 : 45-53.
66. Bajorek JG, Lee RJ Lomax P. Neuropeptides : A role as endogenous mediators or modulators of epileptic phenomena. Ann Neurol 1984; 16 : S31-S38.
67. Buisson A, Lakhmeche N, Verrecchia C, Plotkine M, Boulu RG. Nitric oxide : an endogenous anticonvulsant substance. Neuroreport 1993; 4 : 444-446.
68. Osonoe K, Mori N, Suzuki K, Osonoe M. Antiepileptic effects of inhibitors of nitric oxide synthase examined in pentylenetetrazole-induced seizures in rats. Brain Res 1994; 663 : 338-340.
69. O'Brien DR. The adenosine hypothesis of epilepsy. Medical Hypotheses 1988; 27 : 281-284.
70. Holton FA, Holton P. The capillary dilator substances in dry powders of spinal roots; a possible role of adenosine triphosphate in chemical transmission from nerve endings. J Physiol (Lond) 1954; 126 : 124-140.
71. Phillis JW, Wu PH. The role of adenosine and its nucleotides in central synaptic transmission. Prog Neurobiol 1981; 16; 187-239.
72. 14C] adenosine derivatives from superfused synaptosome preparations. Effects of depolarizing agents and metabolic inhibitors. Brain Res 1980; 181 : 161-174.
73. Sattin A, Rall TW. The effect of adenosine and adenine nucieotide on the cyclic adenosine 3′, 5' - phosphate content of guinea pig cerebral cortex slices. Mol Pharmacol 1970; 6 : 13-23.
74. Olsson RA, Pearson JD. Cardiovascular purinoceptors. Physiol Rev 1990; 70 : 761-845.
75. Jacobson KA. Specific ligands for the adenosine receptor family. Neurotransmissions 1996; XII : 1-7.
76. Jacobson KA, Van Galen PJM, Williams M. Adenosine receptors : Pharmacology, structure-activity relationships and therapeutic potential. J Med Chem 1992; 35 : 407-422.
77. Rudolphi KA, Schubert P, Parkinson FE, Fredholm BB. Neuroprotective role of adenosine in cerebral ischaemia. Trends Pharmacol Sci 1992; 13 : 439-445.
78. 2 receptors in rat striatal membranes. Proc Natl Acad Sci (U.S.A.) 1991; 88:7238-7241.
79. Ault B, Wang CM. Adenosine inhibits epileptiform activity arising in hippocampal areas CA3. Brit J Pharmacol 1986; 87. 695-703.
80. Maitre M, Ciesielski L, Lehman A, Kempf E, Mandel P. Protective effect of adenosine and nicotinamide against audiogenic seizures. Biochem Pharmacol 1974; 23:2807-2816.
81. Winn HR, Welsh JE, Rubio R, Berne RM. Changes in brain adenosine during bicuculline-induced seizures in rats. Circ Res 1980; 47 : 568-577.
82. During MJ, Spencer DD. Adenosine : a mediator of seizure arrest and postictal refractoriness. Ann Neurol 1992; 32:618-624.
83. Chu NS. Caffeine and aminophylline-induced seizures. Epilepsia 1981; 22 : 85-94.
84. Murray TF, Sylvester D, Schultz CS, Szot P. Purinergie modulation of the seizure threshold for pentylenetetrazole in the rat. Neuropharmacology 1985; 24 : 761-766.
85. Morgan PF, Durcan MJ. Caffeine-induced seizures apparent proconvulsant action of Nethylcarboxamido adenosine (NECA). Life Sci 1990; 47 : 1-8.
86. Ramzan I. Proconvulsant effect of papaverine on theophylline-induced seizures in rats. Clin Exp Pharmacol Physiol 1989; 16 : 425-427.
87. 2 receptor ligands in different chemoconvulsive rodent models. Eur J Pharmacol 1993; 242: 221-228.
88. Malhotra J, Gupta YK. Effect of adenosine receptor modulation on pentylenetetrazole-induced seizures in rats. Brit J Pharmacol 1997; 120 : 282-288.
89. Hosseinzadeh H, Stone TW. The effect of calcium removal on the suppression by adenosine of epileptiform activity in the hippocampus : demonstration of desensitization. Brit J Pharmacol 1994; 112 : 316-322.
90. Asano T, Spector S. Identification of inosine and hypoxanthine as endogenous ligands for the brain benzodiazepine-binding sites. Proc Natl Acad Sci (U.S.A.) 1979; 76 : 977-981.
91. Skolnick P, Syapin PJ, Paugh BA, Moncada V, Marangos PJ, Paul SM. Inosine, an endogenous ligand of the brain benzodiazepine receptor, antagonizes pentylenetetrazole-evoked seizures. Proc Natl Acad Sci (U.S.A.) 1979; 76 :1515-1518.
92. Lewin E. Inosine, hypoxanthine and seizures. Adv Neurol 1983; 34 : 103-105.
93. Zhang G, Franklin PH, Murray TF. Activation of adenosine A1 receptor underlies anticonvulsant effect of CGS 21680. Eur J Pharmacol 1994; 255 : 239-243.
94. Onozuka M, Kishii K, Furuichi HA, Sugaya E. Behaviour of intracellular cyclic nucleotide and calcium in metrazol-induced bursting activity in snail neurons. Brain Res 1983; 269 : 277-286.
95. Itagaki S. Experimental seizure model induced by dibutyryl derivatives of cyclic nucleotides. J Jpn Epil Soc 1983; 1 : 88-98.
96. Gessa GL, Krishna G, Forn J, Tagliamonte A, Brodie BB. Behavioural and vegetative effects produced by dibutyryl cyclic AMP injected in different areas of the brain. Adv Biochem Pharmacol 1970; 3 : 371-381.
97. Williams M. Purine nucleosides and nucleotides as centra nervous system modulators. Ann NY Acad Sci 1990; 603 : 93-107.
98. Yokoi I, Toma J, Liu J, Kabuto H, Mori A. Adenosines scavenged hydroxyl radicals and prevented post-traumatic epilepsy. Free Rad Biol Med 1995; 19 : 473-479.
99. Phillis JW, Wu PH. Interactions between the benzodiazepines and adenosine. J Can Sci Neurol 1980; 7 : 247-249.
100. Phillis JW. Diazepam potentiation of purinergic depression on central neurons. Can J Physiol Pharmacol 1979; 57 : 432-435.
101. Phillis JW, Edstrom JP, Ellis SW, Kirkpatrick JR. Theophylline antagonizes flurazepam-induced depression of cerebral cortical neurons. Can J Physiol Pharmacol 1979; 57 : 917-920.
102. 1 adenosine receptors. J Neurockem 1985; 45 : 1761-1770.
103. Stone TW. Interactions of carbamazepine, chlormethiazole and pentobarbitone with adenosine on hippocampal slices. Gen Pharmacol 1988; 19 : 67-72.
104. Lohse MJ, Boser S, Klotz KN, Schwabe U. Affinities of barbiturates for the GABA-receptor complex and A1 adenosine receptor : a possible explanation of their excitatory effects. Naunyn-Schmiedebergs Arch Pharmacol 1987; 336 : 211-217.
105. Skerritt JH, Johnston GAR, Chow SC. Interactions of the anticonvulsant carbamazepine with adensine receptors. 2. Pharmacological studies. Epilepsia 1983; 24 : 643-652.
106. Daval JL, Deckert J, Weiss SRB, Post RM, Marangos PJ. Upregulation of adenosine A1 receptors and forskolin binding sites following chronic treatment with caffeine or carbamazepine: A quantitative autoradiographic study. Epilepsia 1989; 30: 26-33.
107. Malhotra J, Seth SD, Gupta SK, Gupta YK. Adenosinergic mechanism in anticonvulsant action of diazepam and sodium valproate. Env Toxicol Pharmacol 1996; 1 : 269-277.
108. 1 receptor. Brit J Pharmacol 1993; 110 : 470-476.
109. Von Lubitz DKJE, Paul IA, Ji XD, Carter M, Jacobson KA. Chronic administration of adenosine A1 receptor agonist and antagonist : effect on receptor density and N-methyl-D-aspartate induced seizures in mice. Eur J Pharmacol 1994; 253: 95-99.
110. Czuczwar SJ, Janusz W, Szczepanik B, Kleinrok Z. Influence of CGS 15943A (a nonxanthine adenosine antagonist) on the protection offered by a variety of antiepileptic drugs against maximal electroshock-induced seizures in mice. J Neural Trans [Gen Sect] 1991; 86 : 127-134.
111. Czuczwar SJ, Szczepanik B, Wamil A, Janusz W, Kleinrok Z. Differential effects of agents enhancing purinergic transmission upon the antielectroshock efficacy of carbamazepine, diphenylhydantoin, diazepam, phenobarbital and valproate in mice. J Neural Tans [Gen Sect] 1990; 81 :153-166.